The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $497,289 in first-year total cost, median $248,645.
Most frequent study sections
- Special Emphasis Panel[ZRG1 MDCN-B (55)]2
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL1
- UNIVERSITY OF ALABAMA AT BIRMINGHAM1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Sickle Cell Trait Mice are More Susceptible to Chlorine Exposure and Haptoglobin Improves the Outcomes1R21ES034226-01 | ALISHLASH, AMMAR | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $259,875 | ZRG1 |
| 2022 | High-throughput in vivo discovery of novel countermeasures against organophosphate-induced seizure and status epilepticus using zebrafish1R21NS127345-01 | MCGRAW, CHRISTOPHER | MASSACHUSETTS GENERAL HOSPITAL, MA | $237,414 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.